相关实验视频
Updated: Jun 16, 2026

08:26
Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
Published on: February 23, 2024
1.9K
根据SENECA的研究:根据分子分类来确定子宫内膜癌的病期
Enrique Chacon1, Felix Boria2, R Rajagopalan Lyer3
1Department of Gynecologic Oncology, Universidad de Navarra, Pamplona, Navarra, Spain echaconc@unav.es.
概括
在早期子宫内膜癌中,哨兵淋巴结 (SLN) 的参与因分子亚型而异. p53异常和不匹配修复缺陷组显示较高的SLN转移率,影响分期和治疗决策.
科学领域:
- 妇科瘤学 妇科瘤学
- 分子病理学分子病理学
- 手术瘤学手术瘤学
背景情况:
- 精确的分期对于有效的子宫内膜癌管理至关重要.
- 了解跨分子亚型的哨兵淋巴结 (SLN) 参与对于完善分期和治疗策略至关重要.
- 欧洲妇科瘤学会 (ESGO) 的分类为风险分层提供了一个框架.
研究的目的:
- 评估哨兵淋巴结 (SLN) 在早期 (国际妇科和产科联合会2009年I-II) 子宫内膜癌的参与.
- 评估分子亚型和ESGO风险分类对SLN转移率的影响.
- 通过阐明SLN参与的模式来告知治疗决策.
主要方法:
- 在66个中心对2139名患有I-II期子宫内膜癌患者的SENECA研究数据进行了回顾性分析.
- 患者在2021年1月至2022年12月期间接受了SLN评估的手术,遵循ESGO指南.
- 分子分析 (p53,NSMP,MMRd,POLE) 在术前活检或子宫切除样本上进行;SLN评估采用超级分级或单步核酸放大.
主要成果:
- 总体来说,SLN的参与率为9.6% (205/2139名患者),其中67.8%患有低体积转移.
- 在分子亚型中观察到SLN参与的显著差异:p53异常 (12.50%) 和MMRd (12.40%) 的比率高于NSMP (7.80%) 和POLE-mut (6.30%) (p=0.004).
- 在ESGO风险组中,SLN参与率增加,从2.84% (低风险) 到22.51% (高风险).
结论:
- 分子亚型显著影响 sentinel 淋巴结 (SLN) 参与早期子宫内膜癌.
- 异常的p53和MMRd亚型对SLN转移的倾向更高.
- 这些发现强调了将分子分析纳入子宫内膜癌的分期和治疗计划的重要性.
更多相关视频
05:52Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
Published on: August 19, 2021
11.3K
09:48An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
8.1K
相关概念视频
Meiosis vs. Mitosis
Cell division is necessary for growth and reproduction in organisms. Mitosis aids cell growth and development by dividing somatic cells. In contrast, meiosis causes the division of germ cells and plays an essential role in sexual reproduction. Due to their unique functional requirements, mitosis and meiosis differ from each other in multiple aspects.
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Replicative Cell Senescence
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...